Lifebrain Cerba HealthCare Italia is the leading Group in Italy in laboratory medicine for patients, healthcare facilities and businesses. It is now the largest provider of laboratory clinical analyses in the fields of clinical chemistry, haematology, immunochemistry, microbiology, molecular biology, cytology and pathology.
Structured through a network of laboratories, Hub Central and Mini-Hub, allows to oﬀrire the entire spectrum of laboratory medicine tests, from routine to those of classical and molecular human genetics. The integrated network of laboratories is able to combine technological innovation, skills, quality and ﬂexibility thanks to the sharing of protocols, technologies and experience. Centralization and standardization guarantee the excellent services.
In 2021 Lifebrain joined the Cerba Healthcare with a total in Italy of more than 400 medical centers, 23 laboratory platforms, about 1850 employees and over 1500 freelancers.
At a global level, Cerba Healthcare is present in 47 countries with 1140 operating laboratories, 43 million patients per year and 12,000 employees.
Establishment of the Lifebrain Group, with the objective of creating a network of laboratories in Central Europe, starting in Switzerland.
Entry into the Italian market with the acquisition of the Laboratorio Analasi Guidonia [Guidonia Analysis Laboratory], followed by the first acquisitions in Apulia.
Further acquisitions in Emilia-Romagna, Basilicata, Liguria, Campania, Lombardy and the Marche. Thanks to the growth of its laboratory network, the Lifebrain Group became the leading laboratory group in Lazio.
Sale of the Swiss assets and a strategy of focussing on the Italian market.
Creation of three hubs in the north/centre/south with a total of 145 sites.
The Lifebrain Group became No. 2 in Italy and No. 1 in the Veneto.
Expansion of the Lifebrain Group into four new regions. The network of laboratories extended across 15 regions with 204 sites in Italy.
Lifebrain was acquired by Investindustrial, a group leader in independent investment management, with a capital fund of €6.8 billion.
Acquisition of the Laboratorio Giusto and entry into the environmental and food analysis market. A widespread presence, with 270 laboratories and collection centres in 16 Italian regions, and a turnover exceeding 110 million euros.
The Lifebrain Group continued to increase its presence in Italy with 308 sites in 16 regions and a turnover of 158 million euros.
The Lifebrain Group continued to increase its presence in Italy with 360 sites in 17 regions and a turnover of 160 million euros.
The Group is acquired by Cerba healthcare Italy with a total of 400 medical centers, 23 laboratory platforms, about 1850 employees and over 1500 freelancers.
Chief Executive Officer of Cerba HealthCare since 2010, he joined Cerba Laboratories in 2004 as Deputy Chief Executive Officer and Chief Financial Officer.
General Secretary of the Cerba HealthCare Group since March 2015, responsible for legal, regulatory, real estate and insurance matters.
Chief Executive Officer of Cerba HealthCare Italia since its foundation. He has been Delta Medica CEO for over 10 years.